simendan has been researched along with Anesthesia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellofatto, K; Farruggio, S; Grossini, E; Mary, DA; Mombello, C; Origlia, V; Pollesello, P; Sigaudo, L; Vacca, G; Valente, G | 1 |
Schirmer, U | 1 |
Caimmi, PP; Cattaneo, M; Grossini, E; Mary, DA; Molinari, C; Platini, F; Tessitore, L; Uberti, F; Vacca, G; Valente, G | 1 |
Bernhard-Abt, A; Ettner, U; Heimisch, W; Lange, R; Mendler, N; Schad, H; Tassani, P | 1 |
Cavana, M; Fraticelli, A; Mebazaa, A; Pignataro, C | 1 |
Barisin, A; Barisin, S; Bradic, N; Husedzinovic, I; Sonicki, Z; Tonkovic, D | 1 |
Caimmi, PP; Grossini, E; Molinari, C; Teodori, G; Vacca, G | 1 |
Das, B; Sarkar, C | 1 |
Hettrick, DA; Pagel, PS; Warltier, DC | 1 |
1 review(s) available for simendan and Anesthesia
Article | Year |
---|---|
The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Topics: Adrenergic beta-Antagonists; Anesthesia; Calcium Channels, L-Type; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Intensive Care Units; Myocardial Contraction; Pyridazines; Shock, Cardiogenic; Simendan; Systole; Ventricular Dysfunction, Left | 2003 |
1 trial(s) available for simendan and Anesthesia
Article | Year |
---|---|
Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cardiovascular Diseases; Coronary Artery Bypass; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Monitoring, Intraoperative; Pyridazines; Simendan; Ventricular Function, Left | 2004 |
7 other study(ies) available for simendan and Anesthesia
Article | Year |
---|---|
Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats.
Topics: Anesthesia; Animals; Apoptosis; bcl-2-Associated X Protein; Biopsy; Blood Flow Velocity; Caspase 3; Cell Survival; Decanoic Acids; Glutathione; Hydrazones; Hydroxy Acids; Liver; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphodiesterase Inhibitors; Portal Vein; Potassium Channels; Pyridazines; Rats; Reperfusion Injury; Simendan; Thiobarbituric Acid Reactive Substances | 2014 |
[Is everything which is feasible also sensible?: coronary artery bypass grafting in conscious patients -- a procedure with a perspective?].
Topics: Anesthesia; Anesthesia, Epidural; Consciousness; Coronary Artery Bypass, Off-Pump; Echocardiography, Transesophageal; Electrocardiography; Humans; Hydrazones; Intraoperative Complications; Pyridazines; Simendan; Vasodilator Agents | 2008 |
Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs.
Topics: Anesthesia; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; bcl-2-Associated X Protein; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Cytochromes c; Gene Expression; Heart; Heart Rate; Hydrazones; In Situ Nick-End Labeling; Microtubule-Associated Proteins; Myocardial Ischemia; Myocardium; Necrosis; Proto-Oncogene Proteins c-bcl-2; Pyridazines; Simendan; Sus scrofa; Venous Pressure; Ventricular Function, Left | 2010 |
Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs.
Topics: Anesthesia; Animals; Cardiac Output; Coronary Stenosis; Coronary Vessels; Female; Heart Rate; Hemodynamics; Hydrazones; Injections, Intravenous; Male; Myocardial Contraction; Myocardial Ischemia; Pharmaceutical Vehicles; Pyridazines; Regional Blood Flow; Simendan; Swine; Vasodilator Agents; Venous Pressure | 2002 |
Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig.
Topics: Anesthesia; Animals; Autonomic Nervous System; Blood Gas Analysis; Coronary Circulation; Coronary Vessels; Enzyme Inhibitors; Hemodynamics; Hydrazones; Infusions, Intravenous; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyridazines; Simendan; Swine; Vasodilator Agents | 2005 |
Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
Topics: Adenosine Triphosphate; Anesthesia; Animals; Arrhythmias, Cardiac; Blood Pressure; Heart Rate; Hydrazones; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase Type II; Potassium Channels; Pyridazines; Rabbits; Simendan | 2007 |
Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs.
Topics: Anesthesia; Animals; Cardiac Output; Dogs; Female; Hemodynamics; Hydrazones; Male; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Regional Blood Flow; Simendan | 1996 |